Notice 19 Sep 2025 vaccines, public comment, advisory committee, fda, biological products

💉FDA Notice on Vaccines and Biological Products Advisory Committee Meeting

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Learn More
Notice 8 May 2025 public health, advisory committee, fda, regulatory compliance, pandemic response, healthcare, vaccines, biological products

💉FDA Meeting on 2025-2026 COVID-19 Vaccine Formula

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The committee will meet in an open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States. FDA is establishing a docket for public comment on this document.

Learn More